Search results for CONTACT COLASHIP.SHOP TO
Results found
Displaying items 1081 - 1090 of 1536 in total
-
Export opportunity
Replace Roof FCI Low I- Yazoo City, MS
View Changes 01/06/2025- Amendment 0001 - Site visit meeting minutes, site visit sign in sheet, updated construction wage determination and change bid due date…
-
Export opportunity
16--strut,assy,mlg lh,a
CONTACT INFORMATION|4|N761.17|MXG|215-697-3972|peter.kobryn@navy.mil| ITEM UNIQUE IDENTIFICATION AND VALUATION (JAN 2023)|19|||||||||||||||||||| INSPECTION OF …
-
Export opportunity
Drugs
Conclusion of non-exclusive discount contracts according to §§ 130a para. 8/130c para. 1 SGB V for drugs with the active ingredient formoterol and fluticasone …
-
Export opportunity
Drugs
Conclusion of non-exclusive discount contracts according to §§ 130a para. 8/130c para. 1 SGB V for drugs with the active ingredient Tamoxifen (L02BA01) within …
-
Export opportunity
Drugs
Conclusion of non-exclusive discount agreements pursuant to Sections 130a (8)/130c (1) SGB V for drugs with the active ingredient Natalizumab (L04AA23), s.c. d…
-
Export opportunity
Drugs
Conclusion of non-exclusive rebate contracts according to §§ 130a para. 8/130c para. 1 SGB V for drugs with the active ingredient teriparatide (H05AA02) within…
-
Export opportunity
Drugs
Conclusion of non-exclusive rebate contracts according to §§ 130a para. 8/130c para. 1 SGB V for drugs with the active ingredient Piribedil (N04BC08) within th…
-
Export opportunity
Drugs
Conclusion of non-exclusive rebate contracts according to §§ 130a para. 8/130c para. 1 SGB V for drugs with the active ingredient rotigotine (N04BC09) within t…
-
Export opportunity
Drugs
Conclusion of non-exclusive discount contracts according to §§ 130a para. 8/130c para. 1 SGB V for drugs with the active ingredient Fondaparinux (B01AX05) with…
-
Export opportunity
Drugs
Conclusion of non-exclusive discount contracts according to §§ 130a para. 8/130c para. 1 SGB V for drugs with the active ingredient sarilumab (L04AC14) within …